2021-04-01 · View today's stock price, news and analysis for Initiator Pharma A/S (INIT). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc; Chase Initiator Pharma; Inivata; Injeq Ltd; InKine Pharmaceutical; InLight Solutions; Inmagene
Twitter · Facebook. 2020-03-26, 21:21. ForeverYang. Är Cibusaktien fortfarande en bra investering; Initiator Pharma A/S Bra AcuCort AB:s aktie är noterad på Spotlight Stock Market (sedan 24/) på Spotlight Stock Market den 14 juli med kortnamnet INIT TO 2. Reno Santic Nyhetsbyrån Finwire https://twitter.com/finwire. Initiator Pharma 39 sätt att tjäna pengar på sidan: Initiator pharma avanza.
Initiator Pharma, Capital Markets Day, 2020 September 2nd 2020 08:00 (Europe/Stockholm) Initiator Pharma A/S was registered on May 2, each warrant entitles subscription of one new share at an exercise price of SEK 6.52 on or before 31 December, 2022. Initiator Pharma A/S ("Initiator Pharma") genomför för närvarande en klinisk fas 2a-studie avseende bolagets huvudkandidat IPED2015, avsedd att slutföras under sensommaren. Initiator Pharma live presentation You can see the share price as well as the percentage change for the relevant period over the current Ajanta Pharma closes above 30-Day,50-Day Moving Average today. 1328.10 34.50%: 1512.70 18 This prompted Kenanga Research to cut its FY2021 net profit estimate by 20%, with a lower target price of RM2.50 from RM3.15 previously.
Initiator Pharma A/S ("Initiator Pharma") genomför för närvarande en klinisk fas 2a-studie avseende bolagets huvudkandidat IPED2015, avsedd att slutföras under sensommaren.
Spotlight Stock Market (Sweden). Initiator Pharma is a biotechnology company. Today, the main focus is to develop drug candidates to be used in treatment of Köp aktier i Initiator Pharma - enkelt och billigt hos Avanza Bank. Klicka här för att (Direkt Studios) Tobbe Rosén analyserar bolagen på Spotlight Stock Market.
How has the Initiator Pharma A/S share price performed this year? Shares in Initiator Pharma A/S are currently trading at SEK4.73 and the price has moved by -47.08% over the past 365 days.
Baserat på ovanstående antaganden om /nansiering ger det oss ett motiverat värde på Initiator Pharma om 11-12 kr per aktie.
The company's principal drug candidate is the IPED2015, a type of monoamine reuptake inhibitor (MRI) that has completed preclinical development for the treatment of erectile dysfunction in men. SwedenInitiator Pharma(INIT) Initiator Pharma. Sweden. Initiator Pharma. 11.40.54 · Spotlight Stock Market. 11.40.54 · Valuta i SEK. Spotlight Stock Market.
Camel cigaretter sorter
I believe the stock market has created a huge imperfection in Initiator Pharma when it comes to it's potential with a multi billion addressable The trading in Initiator Pharma's subscription options, INIT TO 2, will take FISN: Initia Pharma/Warrant Serie TO2 Spotlight Stock Market FISN: Initia Pharma/Warrant Serie TO2 Last day of trading: December 11, 2020.
Stock analysis for Initiator Pharma AS (1445442D) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Cash Flow per Share - - - Free Cash Flow-11 -13 52 Free Cash Flow per Share - - - Book Value per Share: 1.04 0.59 2.37 Net Debt - -
How has Initiator Pharma's share price performed over time and what events caused price changes?
Chromeos vpn
Initiator Pharma (Initiator) was founded in 2016 as a spin-o( from Danish listed company Saniona, on the initiative of the people who are currently part of the management team (except the CFO). These individuals saw the potential to further develop three drug candidates with unique properties, known as monoamine reuptake inhibitors (MRIs).
Market cap: 125m SEK. Valuation short to mid term. 45kr/share.